Stark International Lux SARL and SERB SAS, affiliates of Brussels-based SERB Specialty Pharmaceuticals, will pay $800m in cash for Boston Scientific's BTG Specialty Pharmaceuticals business.
The deal announced on 1 December is worth about four times the business’s annual revenue and will close during the...








